Antimicrobial resistance. Its importance and efforts to control it

Autor: Francisco J. Torres-López, Silvia Giono-Cerezo, José Ignacio Santos-Preciado, María del Rayo Morfín-Otero, María Dolores Alcántar-Curiel

Publikováno v: Gaceta medica de Mexico. 156(2)

The World Health Organization estimates that bacterial resistance will cause 10 million deaths by 2050. As part of the Global Action Plan on Antimicrobial Resistance, it proposed networks of specialized laboratories in order to preserve strains and o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48cea68b9cdd0b80b07dad1cc9ed6289
https://pubmed.ncbi.nlm.nih.gov/32285851

Biofilm Formation and Susceptibility to Polymyxin B by a Highly Prevalent Clone of Multidrug-Resistant Acinetobacter baumannii from a Mexican Tertiary Care Hospital

Autor: María Dolores Alcántar-Curiel, Eduardo Rodríguez-Noriega, José Ignacio Santos-Preciado, Roberto Rosales-Reyes, Catalina Gayosso-Vázquez, María del Rayo Morfín-Otero, Ma Dolores Jarillo-Quijada

Publikováno v: Chemotherapy. 61:8-14

Background:Acinetobacter baumannii has emerged as a major cause of hospital-associated infections with increased morbidity and mortality among those affected. Methods: A total of 85 isolates of a highly prevalent multidrug-resistant clone, identified

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b69f8c64dd8286478c74ddb809d8aab
https://doi.org/10.1159/000440605

Profile of bacterial resistance in emergency wards, non-intensive care unit areas, and intensive care units in Mexican hospitals with the antimicrobial stewardship program.

Autor: Garza-González E; Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico., Nunez-Martinez ME; Centro Médico ABC, Observatorio, Mexico City, Mexico., Zuñiga-Mejia P; Centro Médico ABC, Observatorio, Mexico City, Mexico., Márquez-Monzón D; Hospital Angeles Metropolitano, Mexico City, Mexico., Morfín-Otero MDR; Hospital Civil Viejo de Guadalajara, Guadalajara, Mexico., Rodríguez-Noriega E; Hospital Civil Viejo de Guadalajara, Guadalajara, Mexico., Castañeda-Méndez P; Hospital Medica Sur, Mexico City, Mexico., Ramírez-Rodríguez JM; Hospital San Javier, Guadalajara, Mexico., Juárez-Lomelí AG; Hospital San Javier, Guadalajara, Mexico., Quintanilla-Cazarez LJ; Hospital Angeles Valle Oriente, Monterrey, Mexico., Saldivar-Cornejo I; Hospital Oncología Centro Médico XXI, Mexico City, Mexico., Martínez-Resendez M; Hospital San José Tecnológico de Monterrey, Monterrey, Mexico., Ugalde CV; Hospital San José, Queretaro, Mexico., Lugo-Tavera M; Clínica De Merida, Merida, Mexico., Aguilar EG; Hospital Aranda de la Parra Leon, Guanajuato, Mexico., Morales-Reyes JJ; Hospital Civil Nuevo de Guadalajara, Guadalajara, Mexico., Sánchez IGM; Hospital General Miguel Silva, Morelia, Mexico., Morales GDO; Hospital General Miguel Silva, Morelia, Mexico., Navarro-Vargas NV; Hospital Lazaro Cardenas ISSSTE, Chihuahua, Mexico., Vallejo JL; MSD, Mexico City, México., Peréz Bolde-Villarreal C; MSD, Mexico City, México.

Publikováno v: IJID regions [IJID Reg] 2024 Oct 24; Vol. 13, pp. 100474. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).